146 related articles for article (PubMed ID: 11408521)
1. In vivo inhibition of Fas ligand-mediated killing by TR6, a Fas ligand decoy receptor.
Connolly K; Cho YH; Duan R; Fikes J; Gregorio T; LaFleur DW; Okoye Z; Salcedo TW; Santiago G; Ullrich S; Wei P; Windle K; Wong E; Yao XT; Zhang YQ; Zheng G; Moore PA
J Pharmacol Exp Ther; 2001 Jul; 298(1):25-33. PubMed ID: 11408521
[TBL] [Abstract][Full Text] [Related]
2. Significant inhibition of human CD8(+) cytotoxic T lymphocyte-mediated xenocytotoxicity by overexpression of the human decoy Fas antigen.
Kawamoto K; Tanemura M; Nishida T; Fukuzawa M; Ito T; Matsuda H
Transplantation; 2006 Mar; 81(5):789-96. PubMed ID: 16534484
[TBL] [Abstract][Full Text] [Related]
3. Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo.
Rensing-Ehl A; Frei K; Flury R; Matiba B; Mariani SM; Weller M; Aebischer P; Krammer PH; Fontana A
Eur J Immunol; 1995 Aug; 25(8):2253-8. PubMed ID: 7545115
[TBL] [Abstract][Full Text] [Related]
4. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer.
Pitti RM; Marsters SA; Lawrence DA; Roy M; Kischkel FC; Dowd P; Huang A; Donahue CJ; Sherwood SW; Baldwin DT; Godowski PJ; Wood WI; Gurney AL; Hillan KJ; Cohen RL; Goddard AD; Botstein D; Ashkenazi A
Nature; 1998 Dec; 396(6712):699-703. PubMed ID: 9872321
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.
Suzuki N; Ichino M; Mihara S; Kaneko S; Sakane T
Arthritis Rheum; 1998 Feb; 41(2):344-53. PubMed ID: 9485093
[TBL] [Abstract][Full Text] [Related]
6. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
Sylvester PW; Shah S
Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
[TBL] [Abstract][Full Text] [Related]
7. TRAIL inhibits tumor growth but is nontoxic to human hepatocytes in chimeric mice.
Hao C; Song JH; Hsi B; Lewis J; Song DK; Petruk KC; Tyrrell DL; Kneteman NM
Cancer Res; 2004 Dec; 64(23):8502-6. PubMed ID: 15574753
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis provoked by the oxidative stress inducer menadione (Vitamin K(3)) is mediated by the Fas/Fas ligand system.
Caricchio R; Kovalenko D; Kaufmann WK; Cohen PL
Clin Immunol; 1999 Oct; 93(1):65-74. PubMed ID: 10497012
[TBL] [Abstract][Full Text] [Related]
9. Blockade of the Fas/FasL system improves pneumococcal clearance from the lungs without preventing dissemination of bacteria to the spleen.
Matute-Bello G; Liles WC; Frevert CW; Dhanireddy S; Ballman K; Wong V; Green RR; Song HY; Witcher DR; Jakubowski JA; Martin TR
J Infect Dis; 2005 Feb; 191(4):596-606. PubMed ID: 15655784
[TBL] [Abstract][Full Text] [Related]
10. Modulation of T-cell responses to alloantigens by TR6/DcR3.
Zhang J; Salcedo TW; Wan X; Ullrich S; Hu B; Gregorio T; Feng P; Qi S; Chen H; Cho YH; Li Y; Moore PA; Wu J
J Clin Invest; 2001 Jun; 107(11):1459-68. PubMed ID: 11390428
[TBL] [Abstract][Full Text] [Related]
11. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells.
Gopalan B; Litvak A; Sharma S; Mhashilkar AM; Chada S; Ramesh R
Cancer Res; 2005 Apr; 65(8):3017-24. PubMed ID: 15833826
[TBL] [Abstract][Full Text] [Related]
12. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis.
Yu KY; Kwon B; Ni J; Zhai Y; Ebner R; Kwon BS
J Biol Chem; 1999 May; 274(20):13733-6. PubMed ID: 10318773
[TBL] [Abstract][Full Text] [Related]
13. Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure.
Zou Y; Chen T; Han M; Wang H; Yan W; Song G; Wu Z; Wang X; Zhu C; Luo X; Ning Q
J Immunol; 2010 Jan; 184(1):466-75. PubMed ID: 19949088
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular apoptosis is mediated by TNFalpha-dependent Fas/FasLigand cytotoxicity in a murine model of acute liver failure.
Kuhla A; Eipel C; Siebert N; Abshagen K; Menger MD; Vollmar B
Apoptosis; 2008 Dec; 13(12):1427-38. PubMed ID: 18946736
[TBL] [Abstract][Full Text] [Related]
15. DcR3/TR6 effectively prevents islet primary nonfunction after transplantation.
Wu Y; Han B; Luo H; Roduit R; Salcedo TW; Moore PA; Zhang J; Wu J
Diabetes; 2003 Sep; 52(9):2279-86. PubMed ID: 12941767
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effects are produced by forced expression of membrane-bound but not soluble Fas ligand in murine lung carcinoma cells.
Tada Y; O-Wang J; Seimiya M; Takiguchi Y; Tatsumi K; Kuriyama T; Tagawa M
Anticancer Res; 2002; 22(2A):831-6. PubMed ID: 12014659
[TBL] [Abstract][Full Text] [Related]
17. B lymphocytes mediate Fas-dependent cytotoxicity in MRL/lpr mice.
Bonardelle D; Benihoud K; Kiger N; Bobé P
J Leukoc Biol; 2005 Nov; 78(5):1052-9. PubMed ID: 16204618
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin-treated murine peritoneal macrophages induce apoptosis in L929 cells: role of Fas-Fas ligand and tumor necrosis factor-tumor necrosis factor receptor 1.
Chauhan P; Sodhi A; Tarang S
Anticancer Drugs; 2007 Feb; 18(2):187-96. PubMed ID: 17159605
[TBL] [Abstract][Full Text] [Related]
19. DcR3/TR6 modulates immune cell interactions.
Wan X; Shi G; Semenuk M; Zhang J; Wu J
J Cell Biochem; 2003 Jun; 89(3):603-12. PubMed ID: 12761893
[TBL] [Abstract][Full Text] [Related]
20. The role of Fas and FasL as mediators of anticancer chemotherapy.
Poulaki V; Mitsiades CS; Mitsiades N
Drug Resist Updat; 2001 Aug; 4(4):233-42. PubMed ID: 11991678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
